Oncology & Cancer

Stimulating the immune system to fight cancer

Cancer cells have evolved mechanisms to escape the body's immune defense. Agents that prevent immune escape are attractive targets for the development of new cancer therapies. Scientists led by Prof. Herbert Waldmann and ...

Diseases, Conditions, Syndromes

Coronavirus antibodies appear to stop reinfection for months

(HealthDay)—Protective immune system antibodies that develop after being infected with COVID-19 last for at least a few months, a new study suggests. And reinfection does seem to be relatively rare.

Diseases, Conditions, Syndromes

Calls grow for US to rely on rapid tests to fight pandemic

When a Halloween party sparked a COVID-19 outbreak at North Carolina Agricultural and Technical State University, school officials conducted rapid screening on more than 1,000 students in a week, including many who didn't ...

Diseases, Conditions, Syndromes

Studies find having COVID-19 may protect against reinfection

Two new studies give encouraging evidence that having COVID-19 may offer some protection against future infections. Researchers found that people who made antibodies to the coronavirus were much less likely to test positive ...

Oncology & Cancer

Research reveals why some tumors have different makeup of cells

Molecular changes in cells called fibroblasts, which help provide support for tissues throughout the body, may explain why one type of colon cancer doesn't respond to therapy, according to a team of researchers from Weill ...

page 13 from 29